Skip to main content
SpringerLink
Log in

Chryseomonas luteola bloodstream infection in a pediatric patient with pulmonary arterial hypertension receiving intravenous treprostinil therapy

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Treprostinil is a prostacyclin analogue approved for the treatment of pulmonary arterial hypertension (PAH). It is commonly administered through a central venous catheter (CVC). Treprostinil is associated with the incidence of Gram-negative bacterial bloodstream infections (BSI), a susceptibility that has been associated with a diluent used for treprostinil. We report the case of a 14-year-old boy with idiopathic PAH on continuous intravenous treprostinil therapy who presented with fever and fatigue. A blood culture drawn from his CVC was positive for the rare Gram-negative organism Chryseomonas luteola. The patient made a complete recovery with antibacterial treatment. This is the only documented case of a C. luteola BSI in a PAH patient receiving continuous intravenous treprostinil. We recommend maintaining a high index of suspicion for both common and rare Gram-negative pathogens and the early administration of appropriate antibiotic therapy in this population. The use of an alternate diluent solution, such as Sterile Diluent for Flolan, further decreases the infection risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Centers for Disease Control and Prevention. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension—seven sites, United States, 2003–2006. MMWR Morb Mortal Wkly Rep. 2007;56:170–2.

    Google Scholar 

  2. Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:56S–61S.

    Article  PubMed  CAS  Google Scholar 

  3. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, Jöbsis MM, Blackburn SD Jr, Crow JW, Long WA. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334:296–302.

    Article  PubMed  CAS  Google Scholar 

  4. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA. 1997;94:4312–7.

    Article  PubMed  CAS  Google Scholar 

  5. Shapiro SM, Oudiz RJ, Cao T, Romano MA, Beckmann XJ, Georgiou D, Mandayam S, Ginzton LE, Brundage BH. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol. 1997;30:343–9.

    Article  PubMed  CAS  Google Scholar 

  6. Rosenzweig EB, Barst RJ. Idiopathic pulmonary arterial hypertension in children. Curr Opin Pediatr. 2005;17:372–80.

    Article  PubMed  Google Scholar 

  7. Libby P, Warner SJ, Friedman GB. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest. 1988;81:487–98.

    Article  PubMed  CAS  Google Scholar 

  8. Rich JD, Glassner C, Wade M, Coslet S, Arneson C, Doran A, Gomberg-Maitland M. The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. Chest. 2012;141:36–42.

    Article  PubMed  CAS  Google Scholar 

  9. Kuo CH, Ko YC, Yang SN, Chu YT, Wang WL, Huang SK, Chen HN, Wei WJ, Jong YJ, Hung CH. Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation. J Mol Med (Berl). 2011;89:29–41.

    Article  CAS  Google Scholar 

  10. Zaccardelli D, Phares K, Jeffs R, Doran A, Wade M. Stability and antimicrobial effectiveness of treprostinil sodium in sterile diluent for flolan. Int J Clin Pract. 2010;64:885–91.

    Article  PubMed  CAS  Google Scholar 

  11. Kodama K, Kimura N, Komagata K. Two new species of Pseudomonas: P. oryzihabitans isolated from rice paddy and clinical specimens and P. luteola isolated from clinical specimens. Int J Syst Bacteriol. 1985;35:467–74.

    Article  CAS  Google Scholar 

  12. Rahav G, Simhon A, Mattan Y, Moses AE, Sacks T. Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2). Medicine (Baltimore). 1995;74:83–8.

    Article  CAS  Google Scholar 

  13. Kostman JR, Solomon F, Fekete T. Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients. Rev Infect Dis. 1991;13:233–6.

    Article  PubMed  CAS  Google Scholar 

  14. Gaschet A, Engrand C, Piau C, Violette J, Bétrémieux P, Tattevin P, Pladys P, Donnio PY, Jolivet-Gougeon A. Multiple brain abscesses caused by Pseudomonas luteola. Pediatr Infect Dis J. 2009;28:1144–6.

    Article  PubMed  Google Scholar 

  15. Chihab W, Alaoui AS, Amar M. Chryseomonas luteola identified as the source of serious infections in a Moroccan University Hospital. J Clin Microbiol. 2004;42:1837–9.

    Article  PubMed  Google Scholar 

  16. Rastogi S, Sperber SJ. Facial cellulitis and Pseudomonas luteola bacteremia in an otherwise healthy patient. Diagn Microbiol Infectious Dis. 1998;32:303–5.

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Critical Care, Mattel Children’s Hospital UCLA, 10833 Le Conte Avenue, MDCC 12-494, Los Angeles, CA, 90095, USA

    A. Y. Wen

  2. Department of Pediatrics, Division of Critical Care, Mattel Children’s Hospital UCLA and David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, MDCC 12-494, Los Angeles, CA, 90095, USA

    I. K. Weiss & R. B. Kelly

Authors
  1. A. Y. Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. K. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. B. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. B. Kelly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wen, A.Y., Weiss, I.K. & Kelly, R.B. Chryseomonas luteola bloodstream infection in a pediatric patient with pulmonary arterial hypertension receiving intravenous treprostinil therapy. Infection 41, 719–722 (2013). https://doi.org/10.1007/s15010-012-0399-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-012-0399-2

Keywords

Search

Navigation